Our position is that DTC ads are just an extension of the general drug safety problems and the FDA needs broader authority on drug safety generally.
In theory, drug ads could provide some important information to consumers. But as a practical matter, that's not what they do. They promote new drugs. They promote more expensive brand name drugs.
Much of what the industry is proposing is already law, such as producing ads that aren't misleading. What we clearly need is more authority and resources to ensure that all marketing, not just the amount spent on direct-to-consumer advertising, is honest and accurate.